The impact of pharmacogenomic factors on acute persistent rejection in adult lung transplant patients
- 31 March 2005
- journal article
- Published by Elsevier BV in Transplant Immunology
- Vol. 14 (1), 37-42
- https://doi.org/10.1016/j.trim.2004.11.001
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- Interleukin-10 production genotype protects against acute persistent rejection after lung transplantationThe Journal of Heart and Lung Transplantation, 2004
- Pharmacogenomics: The Inherited Basis for Interindividual Differences in Drug ResponseAnnual Review of Genomics and Human Genetics, 2001
- Pharmacogenomics: A Clinician's Primer on Emerging Technologies for Improved Patient CareMayo Clinic Proceedings, 2001
- Transforming growth factor β in relation to cardiac allograft vasculopathy after heart transplantationThe Journal of Thoracic and Cardiovascular Surgery, 2000
- Cytokine gene polymorphisms predict acute graft rejection following renal transplantationKidney International, 1999
- AGE AND LIVER TRANSPLANTATIONTransplantation, 1998
- Conclusions of the corneal transplant follow up studyBritish Journal of Ophthalmology, 1997
- Variation in the Tumor Necrosis Factor- Gene Promoter Region May Be Associated with Death from Meningococcal DiseaseThe Journal of Infectious Diseases, 1996
- Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P‐glycoprotein: Implications for drug delivery and activity in cancer chemotherapyMolecular Carcinogenesis, 1995
- LUNG TRANSPLANTATION IN PATIENTS OVER THE AGE OF 50Transplantation, 1993